控制的EGCG释放从化涂层Ti6Al4V:双价离子对释放和细胞毒性的影响
Wiktoria Stachowicz1, Alicja Wojcik2, Dominika Podbereska3
1Institute of Chemical Technology and Engineering, Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, 60-965 Poznan, Poland.
ACS biomaterials science & engineering
|January 21, 2026
概括
植入物涂有-化石,可提供甲基酸盐 (EGCG) 用于骨愈合. 这些植入物无毒,适用于骨科创伤,促进骨再生,同时尽量减少损伤.
科学领域:
- 生物材料科学 生物材料科学
- 整形外科手术 整形外科手术
- 药物输送系统 药物输送系统
背景情况:
- 植入物是骨科的标准,但可以从增强的功能中受益.
- 乙甲基酸盐 (EGCG) 具有有利于骨再生的骨质生成性,抗吸收性和抗菌性.
- 从植入物表面控制药物输送可以改善治疗结果并最大限度地减少副作用.
研究的目的:
- 开发植入物,涂层有热带石层,用于可控的表甲基酸盐 (EGCG) 输送.
- 研究双价离子修饰 (Zn2+,Mg2+,Ca2+) 对EGCG吸附和释放动力学的影响.
- 为了评估EGCG载荷的热带石涂层的生物相容性和适合性,用于骨科应用.
主要方法:
- 岩涂层是在基板上合成的,并用双价离子进行修改.
- 在中性和酸性条件下使用紫外线视光谱学来表征EGCG吸附和释放概况.
- 材料表征包括SEM,EDS,FT-IR和表面造型测量.
- 修改涂层的细胞毒性使用hFOB 1.19骨质细胞被评估.
主要成果:
- 石涂层成功地形成并装载了EGCG,具有可调节的释放配置文件.
- 氧化涂层显示出受控的,无毒的EGCG释放,并且不支持细胞粘附.
- -化石涂层显示高EGCG吸附,但表现出细胞毒性.
- EGCG的释放取决于pH值,在酸性条件下释放更快.
结论:
- 氧化涂层的植入物为骨科创伤管理中局部EGCG输送提供了一个有前途的平台.
- 这些功能性植入物提供机械支持,促进骨再生,并最大限度地减少组织损伤.
- 这种依赖pH值的释放机制允许有针对性的治疗效果,可能是在骨愈合或植入物切除期间.
相关概念视频
01:28Energy-releasing Steps of Glycolysis
146.4K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
The first energy-releasing step—the 6th step of glycolysis...
146.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
01:31ATP Energy Storage and Release
14.0K
ATP is a highly unstable molecule. Unless quickly used to perform work, ATP spontaneously dissociates into ADP and inorganic phosphate (Pi), and the free energy released during this process is lost as heat. The energy released by ATP hydrolysis is used to perform work inside the cell and depends on a strategy called energy coupling. Cells couple the exergonic reaction of ATP hydrolysis with endergonic reactions, allowing them to proceed.
One example of energy coupling using ATP involves a...
One example of energy coupling using ATP involves a...
14.0K
01:10In Vitro Drug Release Testing: Overview, Development and Validation
318
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
318
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
843
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
843
02:54Trends in Lattice Energy: Ion Size and Charge
26.5K
An ionic compound is stable because of the electrostatic attraction between its positive and negative ions. The lattice energy of a compound is a measure of the strength of this attraction. The lattice energy (ΔHlattice) of an ionic compound is defined as the energy required to separate one mole of the solid into its component gaseous ions. For the ionic solid sodium chloride, the lattice energy is the enthalpy change of the process:
26.5K